TREVI THERAPEUTICS INC (TRVI:NASDAQ)
$14.62 -0.78 (-5.0649%)
Analysed TREVI THERAPEUTICS INC (TRVI:NASDAQ) News Sources
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
20-04-2026
yahoo.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Take Positions Amid Corporate Earnings
17-04-2026
yahoo.com
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
17-04-2026
yahoo.com
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
16-04-2026
yahoo.com
A Look At Trevi Therapeutics (TRVI) Valuation After FDA End Of Phase 2 Milestone For IPF Chronic Cough
05-04-2026
yahoo.com
Trevi Therapeutics to Participate in Upcoming Events
01-04-2026
yahoo.com
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?
23-03-2026
fool.com
Trevi Therapeutics Q4 Earnings Call Highlights
18-03-2026
marketbeat.com
Trevi Therapeutics (TRVI) Earnings Transcript
18-03-2026
fool.com
Trevi Therapeutics, Inc. Q4 2025 Earnings Call Summary
18-03-2026
moby.co
What is the current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The current price of TREVI THERAPEUTICS INC (TRVI:NASDAQ) is $14.62.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) absolute price change since previous trading day?
The absolute price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is $-0.78.
TREVI THERAPEUTICS INC (TRVI:NASDAQ) percentage price change since previous trading day?
The percentage price change of TREVI THERAPEUTICS INC (TRVI:NASDAQ) since the previous trading day is -5.0649%.
What is the most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent average sentiment score for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ)?
The most recent sentiment for TREVI THERAPEUTICS INC (TRVI:NASDAQ) is .
SEC-8K** Filing Available For TREVI THERAPEUTICS INC (TRVI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.